For the very first time, bioplastic can be used to diagnose and treat tumours thanks to the first patent registered by Bio-on in the nanomedical field, particularly in nanodiagnostics (nano-imaging).
Bio-on researchers use nanotechnologies to create
minerv BIOMEDS: these are revolutionary and innovative nanocapsules in PHAs bioplastic (polyhydroxyalkanoates) capable of simultaneously containing two contrast media: magnetic nanoparticles and gold nanocylinders.
These two elements flag up diseased areas of the body, e.g. a tumour mass, using traditional
Nuclear Magnetic Resonance and the more innovative
Photoacoustic imaging*.
"Using PHA bioplastic is very advantageous," explains Prof.
Mauro Comes Franchini, Bio-on Chief Scientific Advisor, "because it is safe for the patient and has no side effects.
As an industrial chemist, my main goal is to work with products that are safe for the environment and human health, especially when it comes to biomedical applications.
Bio-on bioplastics fully meet these requirements and open up important, unexplored fields for nanotechnologies in medicine - a rapidly growing sector."